Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review)
- 4 December 2025
- journal article
- review article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 68 (2) , 1-15
Abstract
Cancer stem cells (CSCs), a small subpopulation of cancer cells that exhibit stem‑like properties, possess the ability to differentiate and self‑renew. These capabilities enable CSCs to act as tumor‑initiating cells, driving tumorigenesis and proliferation, leading to major clinical challenges. Specifically, CSCs play a crucial role in metastasis, recurrence and drug resistance, thereby leading to complications in therapeutic responses. The plasticity of CSCs leads to heterogeneity, allowing them to adopt diverse phenotypes in response to intrinsic genetic factors or extrinsic environmental cues. This adaptability may serve as a mechanism for CSCs to thrive in the tumor microenvironment (TME) and promote tumor progression. The present article aimed to review the multifaceted nature of CSCs, examining their functional diversity, biomarkers and interactions with the TME. Through elucidating the mechanisms that underlie this heterogeneity, researchers aim to develop targeted therapeutic interventions against CSCs, thereby enhancing the efficacy of cancer treatments and improving patient outcomes.Keywords
This publication has 163 references indexed in Scilit:
- Caregiver fear of cancer recurrence: A systematic review and meta‐analysis of quantitative studiesPsycho-Oncology, 2023
- Multiplex immunofluorescence and single‐cell transcriptomic profiling reveal the spatial cell interaction networks in the non‐small cell lung cancer microenvironmentClinical and Translational Medicine, 2023
- Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cellsCancer Immunology, Immunotherapy, 2022
- Lipid raft‐disrupting miltefosine preferentially induces the death of colorectal cancer stem‐like cellsClinical and Translational Medicine, 2021
- Microfluidic Tandem Mechanical Sorting System for Enhanced Cancer Stem Cell Isolation and Ingredient ScreeningAdvanced Healthcare Materials, 2021
- AIBP, Angiogenesis, Hematopoiesis, and AtherogenesisCurrent Atherosclerosis Reports, 2020
- A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma ProgressionHepatology, 2019
- Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinomaCancer Medicine, 2019
- Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinomaHepatology, 2018
- Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapyJournal of Neuro-Oncology, 2007